Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to avoid kidney failure and stay alive. Despite the severity of the condition, there are ...

Lubiprostone is the only product approved for use in IBS-C which includes a mechanism of action for reducing intestinal permeability. For further information please see the complete Prescribing ...

Bethesda, Md., and Lincolnshire, Il.– Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc., announced today that AMITIZA (lubiprostone), 24-mcg soft-gel capsules, approved by ...

First treatment approved for opioid-induced constipation The FDA has expanded the indication for oral lubiprostone (Amitiza) to include opioid-induced constipation in chronic pain patients. The FDA ...